ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $386,000 | -44.8% | 94,141 | -51.9% | 0.00% | – |
Q4 2021 | $699,000 | +33.9% | 195,823 | +36.4% | 0.00% | – |
Q3 2021 | $522,000 | -15.3% | 143,610 | +1.7% | 0.00% | – |
Q2 2021 | $616,000 | -34.8% | 141,214 | -38.6% | 0.00% | – |
Q1 2021 | $945,000 | +16.2% | 229,858 | +12.8% | 0.00% | – |
Q4 2020 | $813,000 | +40.9% | 203,766 | -4.6% | 0.00% | – |
Q3 2020 | $577,000 | +28.2% | 213,534 | +30.5% | 0.00% | – |
Q2 2020 | $450,000 | +111.3% | 163,576 | +80.8% | 0.00% | – |
Q1 2020 | $213,000 | -61.9% | 90,483 | -23.9% | 0.00% | – |
Q4 2019 | $559,000 | -19.1% | 118,862 | -42.5% | 0.00% | – |
Q3 2019 | $691,000 | +73.6% | 206,548 | +70.8% | 0.00% | – |
Q2 2019 | $398,000 | +53.7% | 120,944 | +41.7% | 0.00% | – |
Q1 2019 | $259,000 | -6.2% | 85,377 | -15.9% | 0.00% | – |
Q4 2018 | $276,000 | +71.4% | 101,544 | +112.6% | 0.00% | – |
Q3 2018 | $161,000 | +43.8% | 47,772 | +10.1% | 0.00% | – |
Q2 2018 | $112,000 | -6.7% | 43,381 | -20.5% | 0.00% | – |
Q1 2018 | $120,000 | +106.9% | 54,557 | +84.2% | 0.00% | – |
Q4 2017 | $58,000 | +13.7% | 29,614 | +87.7% | 0.00% | – |
Q3 2017 | $51,000 | +112.5% | 15,778 | +112.5% | 0.00% | – |
Q2 2017 | $24,000 | +41.2% | 7,424 | +21.0% | 0.00% | – |
Q1 2017 | $17,000 | +41.7% | 6,135 | +22.7% | 0.00% | – |
Q4 2016 | $12,000 | +50.0% | 5,002 | -3.7% | 0.00% | – |
Q3 2016 | $8,000 | -85.2% | 5,193 | -89.9% | 0.00% | – |
Q2 2016 | $54,000 | +2600.0% | 51,390 | +1955.6% | 0.00% | – |
Q1 2016 | $2,000 | -71.4% | 2,500 | -60.0% | 0.00% | – |
Q4 2015 | $7,000 | 0.0% | 6,247 | +44.5% | 0.00% | – |
Q3 2015 | $7,000 | -97.1% | 4,322 | -96.3% | 0.00% | – |
Q2 2015 | $242,000 | +2925.0% | 116,652 | +3707.2% | 0.00% | – |
Q1 2015 | $8,000 | -88.7% | 3,064 | -88.9% | 0.00% | – |
Q4 2014 | $71,000 | -66.7% | 27,510 | -76.3% | 0.00% | – |
Q3 2014 | $213,000 | +475.7% | 116,107 | +747.5% | 0.00% | – |
Q2 2014 | $37,000 | -75.5% | 13,700 | -68.2% | 0.00% | – |
Q1 2014 | $151,000 | +694.7% | 43,082 | +929.4% | 0.00% | – |
Q4 2013 | $19,000 | -79.8% | 4,185 | -81.9% | 0.00% | – |
Q3 2013 | $94,000 | -25.4% | 23,058 | -24.0% | 0.00% | – |
Q2 2013 | $126,000 | – | 30,353 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |